SUPPLY AGREEMENTSupply Agreement • August 7th, 2008 • Amag Pharmaceuticals Inc. • In vitro & in vivo diagnostic substances • New York
This SUPPLY AGREEMENT (the “Agreement”) is made and entered into as of the day of May, 2008 (the “Effective Date”) by and between AMAG PHARMACEUTICALS, INC., a Delaware corporation with its principal place of business at 125 CambridgePark Drive, Cambridge, MA 02140, U.S.A. (“AMAG”), and 3SBIO INC., a company incorporated under the laws of the Cayman Islands, with a place of business at No. 3 A1 Road 10, Shenyang Economy & Technology Development Zone, Shenyang, 110027, China (“3SBio”). AMAG and 3SBio are sometimes referred to herein individually as a “Party” and collectively as the “Parties.”
COLLABORATION AND EXCLUSIVE LICENSE AGREEMENTCollaboration and Exclusive License Agreement • August 7th, 2008 • Amag Pharmaceuticals Inc. • In vitro & in vivo diagnostic substances • New York
[***] INDICATES MATERIAL THAT HAS BEEN OMITTED AND FOR WHICH CONFIDENTIAL TREATMENT HAS BEEN REQUESTED. ALL SUCH OMITTED MATERIAL HAS BEEN FILED WITH THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO RULE 24b-2 PROMULGATED UNDER THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED.
